Home/Filings/4/0001209191-23-009634
4//SEC Filing

Millian Craig Stuart 4

Accession 0001209191-23-009634

CIK 0001595097other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 12:53 PM ET

Size

5.6 KB

Accession

0001209191-23-009634

Insider Transaction Report

Form 4
Period: 2023-02-13
Millian Craig Stuart
Chief Commercial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-13+934,645934,645 total
    Exercise: $0.14Exp: 2033-02-13Common Stock (934,645 underlying)
Footnotes (1)
  • [F1]The annual option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on February 13 2024, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on March 13, 2024.

Issuer

Corbus Pharmaceuticals Holdings, Inc.

CIK 0001595097

Entity typeother

Related Parties

1
  • filerCIK 0001769163

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 12:53 PM ET
Size
5.6 KB